Today: 9 June 2026
Adobe stock jumps 4% ahead of March 12 earnings — what investors will be listening for
3 March 2026
1 min read

Adobe stock jumps 4% ahead of March 12 earnings — what investors will be listening for

New York, March 3, 2026, 15:02 EST — Regular session

  • Adobe shares climbed, bucking the drop in the broader U.S. market.
  • Fiscal Q1 results drop after the bell March 12, the company said.
  • Investors now await new cues on how AI is turning into revenue—and when deals might land.

Adobe Inc climbed $10.81, or 4.1%, to $271.69 by mid-afternoon Tuesday—one of the few bright spots as U.S. markets sagged. Shares ranged from $255.65 to $272.78. The Nasdaq 100 and S&P 500 each slipped, dropping around 0.7% and 0.6%, respectively. Adobe’s valuation hovered close to $151 billion.

Just a day earlier, the San Jose, California-based firm announced plans to report first-quarter fiscal 2026 earnings after the close on Thursday, March 12, with a conference call set for 2 p.m. Pacific Time.

That shifts attention to Adobe’s guidance—and not only the latest quarter. Investors are searching for clarity on the pace at which generative AI features convert into paid upgrades, higher pricing, or better renewal rates, as fresh tools flood the space.

Back in December, Adobe projected fiscal 2026 revenue between $25.90 billion and $26.10 billion, along with adjusted earnings per share in the $23.30 to $23.50 range—figures that beat analyst estimates at the time. CFO Dan Durn told Reuters the company was experiencing “significant strength in Creative Cloud Pro, Photoshop, Lightroom,” and noted monthly active users for its freemium offerings had jumped 35%, crossing 70 million. Adobe added it plans to update some of its forecasting and reporting methods starting in fiscal 2026. Reuters

There’s another deal happening, too. Semrush—set to be bought by Adobe after their November agreement—said Monday it’s targeting a closing in the first half of 2026. That’s pending regulatory signoff and the typical closing steps. According to the company, the U.S. Hart-Scott-Rodino antitrust waiting period ended in January, and shareholders gave their approval back in February.

Next week, eyes turn to how Adobe’s Creative Cloud and Document Cloud subscriptions are holding up, plus any specific signs of momentum from Firefly—the company’s generative AI suite. A tweak in the company’s guidance could end up outweighing whether earnings merely top or miss estimates for the quarter.

Investors will be paying close attention to what Adobe says about marketing and ad spend trends in its Experience Cloud segment—a unit where clients haven’t always been eager to spend. The stock’s missing piece has been a more direct link between product adoption and revenue.

Yet Adobe’s relationship with the AI boom remains complicated. Last June, CFRA’s Angelo Zino pointed to “increasing concerns … and a longer time horizon to reach notable AI monetization,” while RBC made clear that competition could delay any payoff from new ventures. If the company strikes a similar note on March 12, it could quickly put Tuesday’s rebound to the test. Reuters

Adobe reports after the bell on March 12. Investors want a new outlook, plus more specifics on AI monetization and when the Semrush deal might close.

Stock Market Today

  • Rocket Lab Stock Price Forecast: AI Analyst Cautions Despite 60% Surge
    June 9, 2026, 10:12 AM EDT. Shares of Rocket Lab USA ($RKLB) have jumped more than 60% year-to-date due to increased demand for small-satellite launches. Despite the rally, AI-driven analysis from TipRanks highlights caution, urging investors to consider potential market volatility and competitive pressures. Rocket Lab's growth taps into expanding satellite deployment, but risks remain in a crowded aerospace sector. Investors should balance optimism with these cautionary signals from advanced analytics.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
MARA stock jumps premarket as annual filing opens door to selling bitcoin stash
Previous Story

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR
Next Story

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

Go toTop